Pre-made Vantictumab benchmark antibody ( Whole mAb, anti-FZD Family therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-ab-611

Pre-Made Vantictumab biosimilar, Whole Mab: Anti-FZD Family therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Vantictumab is a human IgG2 monoclonal antibody designed for the treatment of cancer.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package List Price(In USD) Discount off Discount Price
GMP-Bios-ab-611-1mg 1mg 3090 Inquiry Inquiry

Size: 1mg | 10mg | 100mg


Products Name (INN Index) Pre-Made Vantictumab biosimilar, Whole Mab: Anti-FZD Family therapeutic antibody
INN Name Vantictumab
TargetFZD Family
FormatWhole mAb
Species ReactivityHuman
CH1 IsotypeIgG2
VD LCLambda
Highest_Clin_Trial (Jan '20)Phase-I
Est. StatusDiscontinued
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2013
Year Recommended2014
CompaniesBayer HealthCare Pharmaceuticals;OncoMed Pharmaceuticals
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedBreast cancer;Non-small cell lung cancer;Pancreatic cancer
Development TechMorphoSys HuCAL Phage Display